Is there a future for SGLT2 therapy to treat kidney failure in US Veterans living with autosomal dominant polycystic kidney disease?

Abstract:A patient voice piece discussing the future of SGLT2 therapy to treat kidney failure in US Veterans living with autosomal dominant polycystic kidney disease.

Read the full article
Report a problem with this article